Binding characteristics of seven inhibitors of human aromatase: A site- directed mutagenesis study

Cancer Research

Volumn 56, Issue 15, 1996, Pages 3451-3460

  Kao, Yeh Chih ^a   Cam, Linh L ^a   Laughton, Charles A ^b   Zhou, Dujin ^a   Chen, Shiuan ^a  

^a CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

^b INSTITUTE OF CANCER RESEARCH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

7ALPHA (4 AMINOPHENYLTHIO)ANDROSTENEDIONE; AMINOGLUTETHIMIDE; ANASTROZOLE; ANDROSTENEDIONE; AROMATASE; AROMATASE INHIBITOR; CYTOCHROME P450; FORMESTANE; LETROZOLE; MDL 101003; MUTANT PROTEIN; POLYCLONAL ANTIBODY; UNCLASSIFIED DRUG; VOROZOLE;

ANIMAL CELL; ARTICLE; BINDING AFFINITY; CHO CELL; COMPUTER MODEL; CONTROLLED STUDY; DRUG BINDING; DRUG STRUCTURE; ENZYME ACTIVE SITE; ENZYME STRUCTURE; NONHUMAN; PRIORITY JOURNAL; SITE DIRECTED MUTAGENESIS;

AMINO ACID SEQUENCE; ANIMALS; AROMATASE; AROMATASE INHIBITORS; BACTERIAL PROTEINS; CAMPHOR 5-MONOOXYGENASE; CHO CELLS; CRICETINAE; CYTOCHROME P-450 ENZYME SYSTEM; ENZYME INHIBITORS; FEMALE; HUMANS; MIXED FUNCTION OXYGENASES; MOLECULAR SEQUENCE DATA; MUTAGENESIS, SITE-DIRECTED; PROTEIN CONFORMATION; RABBITS; SEQUENCE HOMOLOGY, AMINO ACID;

EID: 0030013560     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (53)

1. MacLusky, N. J., Clark, A. S., Naftolin, F., and Goldman-Rakic, P. S. Estrogen formation in the mammalian brain: possible role of aromatase in sexual differentiation of the hippocampus and neocortex Steroids, 50: 459-474, 1987.
2. Killinger, D. W., Perel, E., Daiilescu, D., Kharlip, L., and Blackstein, M. E. Aromatase activity in the breast and other peripheral tissues and its therapeutic regulation. Steroids, 50: 523-535, 1987.
3. Miller, W. R., and O'Neill, J. The importance of local synthesis of estrogen within the breast. Steroids, 50: 537-548, 1987.
4. Silva, M. C., Rowlands, M. G., Dowsett, M., Gusterson, B., McKinna, J. A., Fryatt, I., and Coombes, R. C. Intratumoral aromatase as a prognostic factor in human breast carcinoma. Cancer Res., 49: 2588-2591, 1989.
5. Reed, M. J., Owen, A. M., Lai, L. C., Coldham, N. G., Ghilchik, M. W., Shaikh, N. A., and James, V. H. T. In situ oestrone synthesis in normal breast and breast tumour tissues: effect of treatment with 4-hydroxyandrostenedione Int. J. Cancer, 44: 233-237, 1989.
6. Esteban, J. M., Warsi, Z., Haniu, M., Hall, P. F., Shively, J. E., and Chen, S. Detection of intratumoral aromatase in breast carcinomas, an immunohistochemical study with clinico-pathologic correlation J. Am. Pathol., 140: 337-343, 1992.
7. Zhou, D., Pompon, D., and Chen, S. Structure-function studies of human aromatase by site-directed mutagenesis: kinetic properties of mutants Pro308-Phe, Tyr361-Phe, Tyr361-Leu, and Phe406-Arg. Proc. Natl. Acad. Sci. USA, 88: 410-414, 1991.
8. Zhou, D., Korzekwa, K. R., Poulos, T., and Chen, S. A site-directed mutagenesis study of human placental aromatase. J. Biol. Chem., 267: 762-768, 1992.
9. Kadohama, N., Yarborough, C., Zhou, D., Chen, S., and Osawa, Y. Kinetic properties of aromatase mutants Pro308Phe, Asp309Asn, and Asp309Ala, and their interactions with aromatase inhibitors. J. Steroid Biochem. Mol. Biol., 43: 693-701, 1992.
10. Chen, S., and Zhou, D. Functional domains of aromatase cytochrome P450 inferred from comparative analyses of amino acid sequences and substantiated by site-directed mutagenesis experiments. J. Biol. Chem., 267: 22587-22594, 1992.
11. Kadohama, N., Zhou, D., Chen, S., and Osawa, Y. Catalytic efficiency of expressed aromatase following site-directed mutagenesis. Biochim. Biophys. Acta, 1163: 195-200, 1993.
12. Chen, S., Zhou, D., Swiderek, K. M., Kadohama, N., Osawa, Y., and Hall, P. F. Structure-function studies of human aromatase. J. Steroid Biochem. Mol. Biol., 44: 347-356, 1993.
13. Zhou, D., Cam, L. L., Laughton, C. A., Korzekwa, K. R., and Chen, S. A mutagenesis study at a postulated hydrophobic region near the active site of aromatase cytochrome P450 J. Biol. Chem., 269: 19501-19508, 1994.
14. Poulos, T. L., Finzel, B. C., Gunsalus, I. C., Wagner, G. C., and Kraut, J. The 2.6 A crystal structure of Pseudomonas putida cytochrome P-450. J. Biol. Chem., 260: 16122-16130, 1985.
15. Banting, L., Smith, H. J., James, M., Jones, G., Nazareth, W., Hewlins, M. J. E., and Rowlands, M. G. Structure-activity relationships for non-steroidal inhibitors of aromatase. J. Enzyme Inhib., 2: 215-229, 1988.
16. Furet, P., Batzl, C., Bhatnagar, A., Francotte, E., Rihs, G., and Lang, M. A model for the relative binding modes of azole and steroidal inhibitors of aromatase. J. Med. Chem., 36: 1393-1400, 1993.
17. Laughton, C. A., Zvelebil, M. J., and Neidle, S. A detailed molecular model for human aromatase. J. Steroid Biochem. Mol. Biol., 44: 399-407, 1993.
18. Ravichandran, K. G., Boodupalli, S. S., Haseman, C. A., Peterson, J. A., and Deisenhofer, J. Crystal structure of hemoprotein domain of P450BM-3, a prototype of microsomal P450's. Science (Washington DC), 261: 731-736, 1993.
19. Haseman, C. A., Ravichandran, K. G., Peterson, J. A., and Deisenhofer, J. Crystal structure and refinement of cytochrome P450terp at 2 3Å resolution J. Mol. Biol., 236: 1169-1185, 1994.
20. Cupp-Vickery, J. R., and Poulos, T. L. Structure of cytochrome P450eryF involved in erythromycin biosynthesis. Nat. Struct. Biol., 2: 144-153, 1995.
21. Narhi, L. O., and Fulco, A. J. Characterization of a catalytically self-sufficient 119,000-dalton cytochrome P-450 monooxygenase induced by barbiturates in Bacillus megaterium. J. Biol. Chem., 261: 7160-7169, 1986.
22. Narhi, L. O., and Fulco, A. J. Identification and characterization of two functional domains in cytochrome P-450BM-3, a catalytically self-sufficient monooxygenase induced by barbiturates in Bacillus megaterium J. Biol. Chem., 262: 6683-6690, 1987.
23. Amarneh, B., Corbin, C. J., Peterson, J. A., Simpson, E. R., and Graham-Lorence, S. Functional domains of human aromatase cytochrome P450 characterized by molecular modelling and site-directed mutagenesis Mol. Endocrinol., 7: 1617-1624, 1993.
24. Graham-Lorence, S., Amarneh, B., White, R. E., Peterson, J. A., and Simpson, E. R. A three-dimensional model of aromatase cytochrome P450. Protein Sci., 4: 1065-1080, 1995.
25. 19 steroid. J. Biol. Chem., 262: 8685-8689, 1987.
26. Peet, N. P., Johnston, J. O., Burkhart, J. P., and Wright, C. L. A-Ring bridged steroids as potent inhibitors of aromatase. J. Steroid Biochem. Mol. Biol., 44: 409-420, 1993.
27. Bhatnagar, A. S., Hausler, A., Schieweck, K., Lang, M., and Bowman, R. Highly selective inhibition of estrogen biosynthesis by CGS 20267, a new non-steroidal aromatase inhibitor. J. Steroid Biochem. Mol. Biol., 37: 1021-1027, 1990.
28. Dukes, M., Edwards, P. N. Large, M., Smith, I. K., Frank, R., Yates, R. A., Deberardinis, M., and Plourde, P. V. ICI D1033, a new, selective, non-steroidal aromatase inhibitor (Abstract). Third International Conference on Aromatase (p. 30), Bologna, Italy, June 14-17, 1992.
29. Wouters, W., De Coster, R., Krekels, M., Van Dun, J., Beerens, D., Haelterman, C., Raeymaekers, A., Freyne, E., Van Gelder, J., Venet, M., and Janssen, P. A. J. R 76713 a new specific non-steroidal aromatase inhibitor. J. Steroid Biochem., 32: 781-788, 1989.
30. Nelson, R. M., and Long, G. L. A general method of site-specific mutagenesis using a modification of the Thermus aquaticus polymerase chain reaction. Anal. Biochem., 180, 147-151, 1989.
31. Gunning, P., Leavitt, J., Muscat, G., Ng, S-Y., and Kedes, L. A human β-actin expression vector system directs high-level accumulation of antisense transcripts. Proc. Natl. Acad. Sci. USA, 84: 4831-4835, 1987.
32. Zhou, D., Pompon, D., and Chen, S. Stable expression of human aromatase cDNA in mammalian cells, a useful system for aromatase inhibitor screening. Cancer Res., 50: 6949-6954, 1990.
33. Nelson, D. R. Cytochrome P450 nomenclature and alignment of selected sequences. In: R. R. Ortiz de Montellano (ed.), Cytochrome P450 Structure, Mechanism and Biochemistry, 2nd ed., pp. 575-606 New York: Plenum Press, 1995.
34. Rost, B., and Sander, C. Prediction of protein structure at better than 70% accuracy. J. Mol. Biol., 232: 584-599, 1993.
35. Rost, B., and Sander, C. Combining evolutionary information and neural networks to predict protein secondary structure. Proteins, 19: 55-72, 1994.
36. Laughton, C. A. Prediction of protein side-chain conformations from local three-dimensional homology relationships. J. Mol. Biol., 235: 1088-1097, 1994.
37. Pearlman, D. A., Case, D. A., Caldwell, J. C., Seobe, G. L., Chandra Singh, U., Weiner, P., and Kollman, P. A. AMBER 4.0, University of California, San Francisco, CA, 1991.
38. Laskowski, R. A., MacArthur, M. W., Moss, D. S., and Thornton, J. M. PROCHECK: a program to check the stereochemical quality of protein structures. J. Appl. Cryst., 26: 283-291, 1993.
39. Ferrin, T. E., Huang, C. C., Jarvis, L. E., and Langridge, R. The MIDAS display system. J. Mol. Graph., 6: 13-27, 1988.
40. Yoshida, N., and Osawa, Y. Purification of human placental aromatase cytochrome P450 with monoclonal antibody and its characterization. Biochemistry, 30: 3003-3010, 1991.
41. Laemmli, U. K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature (Lond.), 227: 680-685, 1970.
42. Sippl, M. J. Recognition of errors in three-dimensional structures of proteins. Proteins, 17: 355-362, 1993.
43. Kraulis, P. J. MOLSCRIPT: a program to produce both detailed and schematic plots of protein structures J. Appl. Cryst., 24: 946-950, 1991.
44. Koymans, L. M. H., Moereels, H., and Vanden Bossche, H. A molecular model for the interaction between vorozole and other non-steroidal inhibitors and human cytochrome P450 10 (P450 aromatase). J. Steroid Biochem. Mol. Biol., 53: 191-197, 1995.
45. Johnston, J. O., Wright, C. L., Burkhart, J. P., and Peet, N. P. Biological characterization of A-ring steroids. J. Steroid Biochem. Mol. Biol., 44: 623-631, 1993.
46. Schwarzel, W. C., Kruggel, W. G., and Brodie, H. J. Studies on the mechanism of estrogen biosynthesis. VII. The development of inhibitors of the enzyme system in human placenta. Endocrinology, 92: 866-880, 1973.
47. Brodie, A. M. H., Garrett, W., Hendrickson, J. R., Tsai-Morris, C-H., Marcotte, C. H., and Robinson, C. H. Inactivation of aromatase in vitro by 4-hydroxy-4-androstene-3,17-dione and 4-acetoxy-4-androstene-3,17-dione and sustained effects in vivo. Steroids, 38: 693-702, 1981.
48. Brueggemeiter, R. W. Aromatase inhibitors - mechanisms of steroidal inhibitors. Breast Cancer Res. Treat., 30: 31-42, 1994.
49. Ebrahimian, S., Chen, H-H., and Brueggemeier, R. W. Synthesis and biochemical studies of 7α-substituted androstene-1,4-diene-3,17-diones as enzyme-activated irreversible inhibitors of aromatase. Steroids, 58: 414-422, 1993.
50. Di Salle, E., Giudici, D., Briatico, G., and Ornati, G. Novel irreversible aromatase inhibitors. Ann. N. Y. Acad. Sci., 595: 357-367, 1990.
51. Bossche, H. V., Willemsens, G., Roels, I., Bellens, D., Moereels, H., Coene, M-C., Le Jeune, L., Lauwers, W., and Jassen, P. A. J. R 76713 and enantiomers: selective, nonsteroidal inhibitors of the cytochrome P450-dependent oestrogen synthesis. Biochem. Pharmacol., 40: 1707-1718, 1990.
52. Poulos, T. L., and Howard, A. J. Crystal structures of the metyrapone and phenylimidazole inhibited complexes of cytochrome P450cam. Biochemistry, 26: 8165-8174, 1987.
53. Liu, X-P., Lambert, D. M., and Abul-Hajj, Y. J. Probing the hydrophobic pocket of the active site of aromatase with 4-phenoxy-7α-(phenylthio)-4-androstene-3,17-dione. J. Med. Chem., 38: 4135-4138, 1995.